DE69900961T2 - Indane-1-ol Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen - Google Patents

Indane-1-ol Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen

Info

Publication number
DE69900961T2
DE69900961T2 DE69900961T DE69900961T DE69900961T2 DE 69900961 T2 DE69900961 T2 DE 69900961T2 DE 69900961 T DE69900961 T DE 69900961T DE 69900961 T DE69900961 T DE 69900961T DE 69900961 T2 DE69900961 T2 DE 69900961T2
Authority
DE
Germany
Prior art keywords
alkyl
indane
derivatives
processes
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69900961T
Other languages
English (en)
Other versions
DE69900961D1 (de
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Adrian Newman-Tancredi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Application granted granted Critical
Publication of DE69900961D1 publication Critical patent/DE69900961D1/de
Publication of DE69900961T2 publication Critical patent/DE69900961T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE69900961T 1998-08-21 1999-08-20 Indane-1-ol Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen Expired - Fee Related DE69900961T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9810601A FR2782515B1 (fr) 1998-08-21 1998-08-21 NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Publications (2)

Publication Number Publication Date
DE69900961D1 DE69900961D1 (de) 2002-04-11
DE69900961T2 true DE69900961T2 (de) 2002-11-07

Family

ID=9529811

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69900961T Expired - Fee Related DE69900961T2 (de) 1998-08-21 1999-08-20 Indane-1-ol Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen

Country Status (19)

Country Link
US (1) US6153625A (de)
EP (1) EP0982305B1 (de)
JP (1) JP2000072748A (de)
CN (1) CN1128144C (de)
AT (1) ATE214064T1 (de)
AU (1) AU747494B2 (de)
BR (1) BR9903867A (de)
CA (1) CA2280596A1 (de)
DE (1) DE69900961T2 (de)
DK (1) DK0982305T3 (de)
ES (1) ES2172294T3 (de)
FR (1) FR2782515B1 (de)
HK (1) HK1026212A1 (de)
HU (1) HUP9902784A3 (de)
NO (1) NO317516B1 (de)
NZ (1) NZ337362A (de)
PL (1) PL194852B1 (de)
PT (1) PT982305E (de)
ZA (1) ZA995321B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ526699A (en) * 2001-01-16 2005-03-24 Astrazeneca Ab 8-amino derivatives and their use in treating migraine
KR100864356B1 (ko) * 2001-01-16 2008-10-17 아스트라제네카 아베 치료용 헤테로시클릭 화합물
SE0103646D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chroman compounds
SE0103647D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chromone compounds
KR20030070916A (ko) * 2001-01-16 2003-09-02 아스트라제네카 아베 치료용 크로몬 화합물
DE10142662B4 (de) * 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
DE10142661B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
DK0982305T3 (da) 2002-06-24
ZA995321B (en) 2000-02-22
PL335012A1 (en) 2000-02-28
NO994041D0 (no) 1999-08-20
CA2280596A1 (fr) 2000-02-21
BR9903867A (pt) 2000-09-05
CN1250051A (zh) 2000-04-12
HUP9902784A3 (en) 2001-03-28
US6153625A (en) 2000-11-28
FR2782515A1 (fr) 2000-02-25
PT982305E (pt) 2002-07-31
CN1128144C (zh) 2003-11-19
AU747494B2 (en) 2002-05-16
EP0982305B1 (de) 2002-03-06
ATE214064T1 (de) 2002-03-15
DE69900961D1 (de) 2002-04-11
NZ337362A (en) 2000-04-28
NO994041L (no) 2000-02-22
FR2782515B1 (fr) 2000-09-22
ES2172294T3 (es) 2002-09-16
HUP9902784A2 (hu) 2000-12-28
JP2000072748A (ja) 2000-03-07
PL194852B1 (pl) 2007-07-31
HU9902784D0 (en) 1999-10-28
HK1026212A1 (en) 2000-12-08
NO317516B1 (no) 2004-11-08
AU4463799A (en) 2000-03-09
EP0982305A1 (de) 2000-03-01

Similar Documents

Publication Publication Date Title
CO5180642A1 (es) Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion
IS6520A (is) Ný efnasambönd
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
HUP0301422A2 (hu) Ösztrogén hatású szereket tartalmazó gyógyászati készítmények
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
DE60140814D1 (de) N-phenyl-2-pyrimidine-amine derivatives
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
HUP0104188A2 (hu) Antranilsav- és tioantranilsav-N-aril-amidok, előállításuk és alkalmazásuk VEGF receptor tirozinkináz inhibítorokként
SE9903760D0 (sv) New compounds
HUP0301690A2 (hu) Szinergikus eljárások és készítmények rák kezelésére
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
ATE316083T1 (de) Adamantanderivate
DK1412354T3 (da) Derivater af triazolylimidazopyridin og af triazolylpurinerne, der er egnede som ligander for adenosin A2a?-receptoren og deres anvendelse som medikamenter
DE60001586D1 (de) Diphenyl-piperidin derivate
ATE300541T1 (de) Pyrazolopyridinderivate
BR0309188A (pt) Compostos pirazolo como agentes antiinflamatórios e analgésicos
SE9903997D0 (sv) New compounds
BR0309305A (pt) Compostos de imidazol como agentes antiinflamatórios e analgésicos
DE60301339D1 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
DE69900961T2 (de) Indane-1-ol Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
HUP0300295A2 (hu) Helyettesített benzamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ITMI20042475A1 (it) Uso di derivati tiazolidinonici come agenti terapeutici
ATE274515T1 (de) Pyrazolopyridinderivate
HUP0004900A2 (hu) Mozgászavarok kezelésére szolgáló, hatóanyagként NMDA-receptor antagonista hatású piperidinszármazékokat tartalmazó gyógyszerkészítmények
MXPA05010783A (es) Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee